125 related articles for article (PubMed ID: 34955058)
1. Chromosome 8 Polysomy Accounting for MYC Over-Expression in Angiosarcoma Arising as Somatic-Type Malignancy in Metastatic Teratoma. Case Report.
Vargas AC; Grimison P; Joy C; Garrone B; Bonar F; Ghahan RM; Davidson T; Maclean FM
Int J Surg Pathol; 2022 Jun; 30(4):462-465. PubMed ID: 34955058
[TBL] [Abstract][Full Text] [Related]
2. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
[TBL] [Abstract][Full Text] [Related]
3. MYC amplification in angiosarcomas arising in the setting of chronic lymphedema of morbid obesity.
Harker D; Jennings M; McDonough P; Mauskar M; Savory S; Hosler GA; Vandergriff T
J Cutan Pathol; 2017 Jan; 44(1):15-19. PubMed ID: 27686553
[TBL] [Abstract][Full Text] [Related]
4. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
[TBL] [Abstract][Full Text] [Related]
5. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
Shon W; Sukov WR; Jenkins SM; Folpe AL
Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
[TBL] [Abstract][Full Text] [Related]
6. MYC Analysis by Fluorescent In Situ Hybridization and Immunohistochemistry in Primary Adrenal Angiosarcoma (PAA): a Series of Four Cases.
Cornejo KM; Hutchinson L; Cyr MS; Nose V; McLaughlin PJ; Iafrate AJ; Sadow PM
Endocr Pathol; 2015 Dec; 26(4):334-41. PubMed ID: 26223194
[TBL] [Abstract][Full Text] [Related]
7. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
[TBL] [Abstract][Full Text] [Related]
8. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J
Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507
[TBL] [Abstract][Full Text] [Related]
10. Clonal evidence for the progression of a testicular germ cell tumor to angiosarcoma.
Idrees MT; Kuhar M; Ulbright TM; Zhang S; Agaram N; Wang M; Grignon DJ; Eble JN; Cheng L
Hum Pathol; 2010 Jan; 41(1):139-44. PubMed ID: 19836053
[TBL] [Abstract][Full Text] [Related]
11. Secondary Angiosarcoma With C-MYC Amplification Following Prophylactic Bilateral Mastectomy and Autologous Breast Reconstruction: Report of a Case and Review of the Literature.
Webb C; Partain N; Koduru P; Hwang H; Sarode VR
Int J Surg Pathol; 2021 Apr; 29(2):205-210. PubMed ID: 32552130
[TBL] [Abstract][Full Text] [Related]
12. MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome.
Morrison C; Radmacher M; Mohammed N; Suster D; Auer H; Jones S; Riggenbach J; Kelbick N; Bos G; Mayerson J
J Clin Oncol; 2005 Dec; 23(36):9369-76. PubMed ID: 16361637
[TBL] [Abstract][Full Text] [Related]
13. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
[TBL] [Abstract][Full Text] [Related]
14. c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.
La Rosa S; Bernasconi B; Vanoli A; Sciarra A; Notohara K; Albarello L; Casnedi S; Billo P; Zhang L; Tibiletti MG; Sessa F
Virchows Arch; 2018 Oct; 473(4):435-441. PubMed ID: 29721608
[TBL] [Abstract][Full Text] [Related]
15. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced breast angiosarcoma with a confirmative feature of c-MYC amplification.
Tajima S; Mochizuki R; Sugimura H; Hoshi S
Jpn J Clin Oncol; 2014 Jul; 44(7):702-3. PubMed ID: 24903854
[No Abstract] [Full Text] [Related]
17. Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract][Full Text] [Related]
18. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.
Guo T; Zhang L; Chang NE; Singer S; Maki RG; Antonescu CR
Genes Chromosomes Cancer; 2011 Jan; 50(1):25-33. PubMed ID: 20949568
[TBL] [Abstract][Full Text] [Related]
19. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast.
Kuba MG; Xu B; D'Angelo SP; Rosenbaum E; Plitas G; Ross DS; Brogi E; Antonescu CR
Histopathology; 2021 Nov; 79(5):836-846. PubMed ID: 34165212
[TBL] [Abstract][Full Text] [Related]
20. MYC immunohistochemistry in angiosarcoma and atypical vascular lesions: practical considerations based on a single institutional experience.
Udager AM; Ishikawa MK; Lucas DR; McHugh JB; Patel RM
Pathology; 2016 Dec; 48(7):697-704. PubMed ID: 27780597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
